Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Kaichi Kaneko"'
Autor:
Hiroki Wakabayashi, Kotaro Iwasaki, Yu Murakami, Kenta Takashima, Kaichi Kaneko, Yasuo Matsuzawa
Publikováno v:
BMC Pulmonary Medicine, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Patients with idiopathic interstitial pneumonia (IIP) often exhibit positivity for myositis-specific antibodies (MSA). However, the significance of this finding remains unclear. In this study, we investigated the association of MS
Externí odkaz:
https://doaj.org/article/b4dcd9dc98484060a6c7b290feba6729
Autor:
Haemin Kim, In Ah Choi, Akio Umemoto, Seyeon Bae, Kaichi Kaneko, Masataka Mizuno, Eugenia Giannopoulou, Tania Pannellini, Liang Deng, Kyung-Hyun Park-Min
Publikováno v:
Bone Research, Vol 12, Iss 1, Pp 1-15 (2024)
Abstract Osteoclasts are multinucleated bone-resorbing cells, and their formation is tightly regulated to prevent excessive bone loss. However, the mechanisms by which osteoclast formation is restricted remain incompletely determined. Here, we found
Externí odkaz:
https://doaj.org/article/5eab2e5afb7f4e7eaba7faad73e127a2
Autor:
Kensuke Namba, Kazutoshi Isobe, Hiroki Wakabayashi, Ryogo Ohashi, Hiromasa Sakurai, Daiki Sakai, Yusuke Irie, Kenta Takashima, Yu Murakami, Kaichi Kaneko, Nobuyuki Hiruta, Yasuo Matsuzawa
Publikováno v:
Respirology Case Reports, Vol 12, Iss 10, Pp n/a-n/a (2024)
Abstract BRAF is a mediator that activates the mitogen‐activated protein kinase pathway. A mutation in BRAF can cause abnormal pathway activation, leading to cell proliferation. In a Phase II study, the combination therapy of the BRAF inhibitor dab
Externí odkaz:
https://doaj.org/article/9dcef2518b7a436daccff34d260194dd
Autor:
Kaichi Kaneko, Hao Chen, Matthew Kaufman, Isaak Sverdlov, Emily M. Stein, Kyung‐Hyun Park‐Min
Publikováno v:
Clinical and Translational Medicine, Vol 11, Iss 10, Pp n/a-n/a (2021)
Abstract Osteonecrosis (ON) is a complex and multifactorial complication of systemic lupus erythematosus (SLE). ON is a devastating condition that causes severe pain and compromises the quality of life. The prevalence of ON in SLE patients is variabl
Externí odkaz:
https://doaj.org/article/57861bab39ce48eb9af1a0648abca0d7
Autor:
Makoto Sumazaki1,2, Kaichi Kaneko3, Masaaki Ito1, Yoko Oshima4, Fumi Saito2, Hideaki Ogata2 hideaki.shimada@med.toho-u.ac.jp, Kazutoshi Shibuya5, Hideaki Shimada1,4
Publikováno v:
American Journal of Case Reports. 4/21/2020, Vol. 21, p1-5. 5p.
Autor:
Seyeon Bae, Kibyeong Kim, Keunsoo Kang, Haemin Kim, Minjoon Lee, Brian Oh, Kaichi Kaneko, Sungkook Ma, Jae Hoon Choi, Hojoong Kwak, Eun Young Lee, Sung Ho Park, Kyung-Hyun Park-Min
Publikováno v:
Cellularmolecular immunology. 20(1)
Monocyte/macrophage lineage cells are highly plastic and can differentiate into various cells under different environmental stimuli. Bone-resorbing osteoclasts are derived from the monocyte/macrophage lineage in response to receptor activator of NF-
Autor:
Emily M. Stein, Kyung-Hyun Park-Min, Isaak Sverdlov, Hao Chen, Kaichi Kaneko, Matthew W Kaufman
Publikováno v:
Clinical and Translational Medicine, Vol 11, Iss 10, Pp n/a-n/a (2021)
Clinical and Translational Medicine
Clinical and Translational Medicine
Osteonecrosis (ON) is a complex and multifactorial complication of systemic lupus erythematosus (SLE). ON is a devastating condition that causes severe pain and compromises the quality of life. The prevalence of ON in SLE patients is variable, rangin
Autor:
Toshihiro Nanki, Soichi Yamada, K. Shikano, Makoto Kaburaki, Shinichi Kawai, Mai Kawazoe, Zento Yamada, Sei Muraoka, Hiroshi Sato, Kaichi Kaneko, Shotaro Masuoka, Satoshi Mizutani
Publikováno v:
Clinical Rheumatology. 38:1571-1578
To assess the renal and non-renal efficacy of mycophenolate mofetil (MMF) in Japanese patients with systemic lupus erythematosus (SLE). We conducted a retrospective study to assess the renal and non-renal efficacies of MMF in Japanese patients with s
Publikováno v:
Cytokine. 146
Osteoclast differentiation is promoted under inflammatory conditions and osteoclasts play a major role in bone destruction in rheumatoid arthritis (RA). Chemokine (C-X3-C motif) ligand 1 (CX3CL1), also known as fractalkine, functions as a chemoattrac
Publikováno v:
Internal Medicine; 2022, Vol. 61 Issue 16, p2405-2415, 11p